市场调查报告书
商品编码
1210916
牛呼吸系统疾病 (BRD) 治疗全球市场规模调查和预测:按治疗、疾病和地区进行的分析,2022-2029 年Global Bovine Respiratory Disease Treatment Market Size study & Forecast, by Material Treatment Type, Disease Type, and Regional Analysis, 2022-2029 |
牛呼吸道疾病药物是指世界范围内发生在牛身上的常见疾病。
包括传染性牛鼻气管炎 (IBR)、牛呼吸道合胞病毒 (BRSV)、牛病毒性腹泻 (BVD) 和 3 型副流感病毒 (PI-3)。 受牛肉消费量增加、牛呼吸道疾病发病率上升等因素影响,治疗牛呼吸道疾病的药物市场正在扩大
根据2022年9月发表的一篇题为《世界牛肉消费量》的文章,根据国家排名(美国农业部),2020年世界牛肉消费量增加1473.4亿磅。 美国将在 2020 年成为牛肉消费量最高的国家,其次是中国、欧盟、巴西和印度。
另一方面,越来越多的白喉病例和市场参与者增加的研发活动为市场创造了有利可图的机会。 然而,熟练兽医的短缺将阻碍整个 2022-2029 年预测期内的市场增长。
全球牛呼吸道疾病治疗市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于牛肉产量和消费量的增加、BRD 病例的增加以及对牛呼吸道治疗的认识不断提高,北美在收入方面占据了市场主导地位。 另一方面,由于 BRD 监控产品的技术进步不断增加以及市场参与者的渗透率不断提高等因素,预计北美地区在预测期内将出现显着增长。
这项研究的目的是定义近年来各个细分市场和国家的市场规模,并预测他们在未来几年的价值。 本报告旨在捕捉被调查国家行业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Bovine Respiratory Disease Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Bovine Respiratory Disease Treatment refers to the common diseases occur to cattle globally. It includes infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD), and parainfluenza type-3 virus (PI-3). The Bovine Respiratory Disease Treatment market is expanding because of factors such as the growing consumption of beef and rising incidences of bovine respiratory diseases
According to the article published in September 2022, titled "World Beef Consumption: Ranking of Countries (USDA)," global beef consumption stood at 147.34 billion pounds in 2020. The United States consumed the most beef in 2020, followed by China, the European Union, Brazil, and India.
Whereas, rising cases of Diphtheria and growing R&D activities by market players create lucrative opportunities for the market. However, the lack of skilled veterinarians hampers the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Bovine Respiratory Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing production and consumption of bovine meat and rising cases of BRD, and increasing awareness of bovine respiratory treatment Whereas North America is expected to grow significantly during the forecast period, owing to factors such as increasing technological advances in products to monitor BRD and growing penetration of market players etc. in the forecast period
Major market players included in this report are:
Bimeda
Boehringer Ingelheim GmbH
Ceva
Elanco
Krka UK Ltd
Merial
Merck & Co. Inc.
Vetoquinol
Virbac
Zoetis Inc.
Recent Developments in the Market:
Global Bovine Respiratory Disease Treatment Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Treatment, Disease, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment:
Vaccines,
Antibiotics,
NSAIDs,
Immunomodulators,
Other Treatment Types
By Disease:
Lower Respiratory Tract Infections,
Upper Respiratory Tract Infections,
Diphtheria
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable